Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Evolving idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever/hyperinflammation, renal dysfunction and organomegaly presenting with severe hypoalbuminaemia, serositis and bicytopenia before lymphadenopathy.

Created on 18 Sep 2026

Authors

John Kachope, Olga Muradov

Published in

BMJ case reports. Volume 19. Issue 9. Sep 17, 2026. Epub Sep 17, 2026.

Abstract

A man in his early 60s presented initially with abdominal symptoms, nutritional deficiencies, severe hypoalbuminaemia, thrombocytopenia and marked inflammation, without clinically apparent lymphadenopathy. Over subsequent hospitalisations, he developed progressive anasarca, pleural and peritoneal serositis, bicytopenia and renal dysfunction. Cardiac, renal, gastrointestinal, infectious, neoplastic and autoimmune explanations were investigated but did not account for the evolving multisystem picture. Lymphadenopathy became evident only later on positron emission tomography-CT, providing the diagnostic pivot. Lymph node assessment, persistent hyperinflammation and the evolving clinical pattern supported idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever/hyperinflammation, renal dysfunction and organomegaly features (iMCD-TAFRO). Treatment with corticosteroids and siltuximab was followed by clinical and biochemical improvement. This case illustrates how TAFRO syndrome may become recognisable before lymphadenopathy makes Castleman disease an obvious consideration.

PMID:
42754350
Bibliographic data and abstract were imported from PubMed on 18 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement